FDA Commissioner Marty Makary breaks down Trump’s executive order on psychedelics
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
Read MoreWhat to know about psychedelic retreats, a booming business with few safety guardrails
Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats
Read MoreTrump signs order to speed up access to psychedelic drug treatments
Donald Trump has signed an executive order speeding up reviews of psychedelic drugs – including for ibogaine, touted as a possible treatment for post-traumatic stress disorder.
Read MoreJoe Rogan joins Trump to sign order allowing psychedelic drug research
Podcaster Joe Rogan joined President Trump and others in the Oval Office on Saturday as he signed an executive order accelerating research for certain psychedelic drugs used to treat mental health disorders. “Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier…
Read MoreTrump Expected to Loosen Restrictions on Psychedelic Drugs
An upcoming executive order is intended to accelerate research into the compounds’ efficacy in treating PTSD, depression and other mental health problems, officials said.
Read More